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is interpreted by proteins that associ-
ate with specific chromosomal loca-
tions. In dissecting the function of these 
chromosome-associated proteins, a 
common assumption has been that a 
given protein performs a single func-
tion in the genome. However, there is 
a growing realization that a single pro-
tein can often be directed to separate 
regions of the genome by independent 
mechanisms to perform distinct biologi-
cal functions. In this issue of Cell, Kind 
et al. (2008) uncover an example of just 
such a system in the fruit fly Drosophila 
melanogaster by examining the genomic 
binding distribution of several proteins, 
including the histone acetyltransferase 
MOF (males-absent-on-the-first), that 
are important for X chromosome gene 
dosage compensation.
MOF, an enzyme that acetylates his-
tone H4 at lysine 16 (H4K16), is a com-
ponent of the Drosophila dosage com-
pensation complex. This complex also 
includes the male-specific lethal proteins 
1–3 (MSL1, MSL2, MSL3), the maleless 
(MLE) protein, and two noncoding RNAs 
called roX1 and roX2 (Straub and Becker, 
2007). This complex binds to the single 
X chromosome of male flies, increasing 
expression of many X-linked transcripts 
2-fold such that expression is equivalent 
to that in female flies, which have two 
X chromosomes. Although the detailed 
mechanism of how the dosage compen-
sation complex acts on the male X chro-
mosome is not clear, it has been pro-
posed that it may promote more efficient 
transcriptional elongation, possibly by 
boosting acetylation of H4K16. Indeed, 
H4K16 acetylation has been shown to 
“loosen” the conformation of chromatin 
in vitro (Shogren-Knaak et al., 2006).
Previous studies have found that 
MSL1 and MSL3 are associated with 
the transcribed regions of genes, with 
a binding pattern that is skewed toward 
the 3′ ends of genes. Therefore, it was 
perhaps not surprising that Kind et 
al. (2008) observed that MOF, like the 
MSL proteins, was also enriched at the 
3′ ends of X-linked genes in a dosage 
compensation-dependent manner. More 
surprising, however, was their observa-
tion of a second mode of MOF binding 
that was completely independent of 
dosage compensation, and was found at 
gene promoters on autosomes and the X 
chromosome. Previously, MOF had been 
singled out as an especially interesting 
member of the dosage compensation 
complex because it was shown to asso-
ciate with several components of the 
nuclear pore (Mendjan et al., 2006). This 
finding raised the intriguing possibility 
that MOF performs functions other than 
dosage compensation at other chromo-
somal locations. Kind and colleagues 
now show that MOF does indeed have 
two functions: a general role in both 
sexes at the gene promoters located on 
either autosomes or the X chromosome, 
and a male-specific role at the 3′ regions 
of transcribed X-linked genes (Figure 1).
The authors performed several experi-
ments in fly tissue culture cells to build 
their case that MOF has two different 
functions. In addition to mapping MOF 
localization, they determined the bind-
ing sites of MSL1 and MSL3, as well 
as the locations of H4K16 acetylated 
nucleosomes using ChIP-chip. The anal-
ysis of male cells containing a single X 
Chromatin Proteins Do Double Duty
Sevinc Ercan1 and Jason D. Lieb1,*




The histone acetyltransferase MOF (males-absent-on-the-first) is required for the regulation of 
X chromosome gene dosage compensation in Drosophila males. In this issue, Kind et al. (2008) 
show that MOF is also found on autosomes and that it has two modes of binding: one in males 
for X chromosome dosage compensation and the other in both sexes for X chromosome and 
autosomal gene regulation independent of dosage compensation.Cell 133, May 30, 2008 ©2008 Elsevier Inc. 763
chromosome and female cells containing 
two X chromosomes allowed the authors 
to identify both dosage compensation-
dependent and dosage compensation-
independent patterns of protein asso-
ciation and chromatin modification. The 
authors also examined changes in gene 
expression in cells depleted of MSL1, 
MSL3, or MOF using RNA interference. 
Although the depletion of MSL1 primar-
ily caused misregulation of X-linked 
genes, depletion of MSL3 and MOF also 
affected some autosomal genes, sug-
gesting that these proteins do not func-
tion only in X chromosome dosage com-
pensation. Further evidence for MOF’s 
autosomal function is based on the 5′ 
bias of the H4K16 acetylation pattern 
within transcribed portions of autosomal 
genes. This acetylation pattern also 
correlated with the presence of MOF. 
Finally, depletion of MOF resulted in the 
loss of most H4K16 acetylation, par-
ticularly at the promoters of autosomal 
genes, suggesting that MOF is respon-
sible for H4K16 acetylation at autosomal 
gene promoters. The function of MOF 
and H4K16 acetylation at promoters is 
not yet known. Studies in the budding 
yeast Saccharomyces cerevisiae do not 
shed much light on the function of H4K16 
acetylation because, in yeast, H4K16 
acetylation is transcription independent 
and is absent from promoters (Liu et al., 
2005).
Proteins required for both X chromo-
some dosage compensation and gen-
eral chromosome function have been 
identified in other systems. One promi-
nent example is a condensin subunit in 
the worm Caenorhabditis elegans called 
mitosis-and-X-associated (MIX-1). This 
protein associates with all chromosomes 
during mitosis but also is required for dos-
age compensation and is associated only 
with the X chromosome during interphase 
(Lieb et al., 1998). The function of MIX-1 
seems to be specified by its binding part-
ners: the protein DPY-27 in the dosage 
compensation complex for repression 
of X-linked genes and a standard SMC4 
partner for mitotic chromosome segre-
gation. A similar mechanism for specify-
ing distinct functions could underlie the 
specification of MOF function.
Targeting of the components of the 
dosage compensation complex, includ-
ing MOF, to the Drosophila male X chro-
mosome is thought to occur stepwise, 
with initial recruitment mediated by the 
MSL1 and MSL2 proteins. This protein 
pair recognizes a limited number of 
sites on the X chromosome (Lyman et 
al., 1997), which may contain short and 
degenerate DNA sequence motifs that 
help to distinguish the X chromosome 
from autosomes (Gilfillan et al., 2007). 
MOF may make its way to these sites of 
initial binding through interactions with 
MSL1 and MSL3 (Straub and Becker, 
2007). After this initial recruitment, the 
dosage compensation complex must 
spread locally to its target genes. Here, in 
addition to DNA sequence-based cues, 
there is also a requirement for the methy-
lation of histone H3 at lysine residue 36 
(H3K36) within transcribed regions with 
a bias to the 3′ ends of genes (Larschan 
et al., 2007). MSL3 binds to trimethylated 
H3K36 and thus may recruit MOF to the 
3′ regions of the genes. Although this 
provides an explanation of MOF bind-
ing at the 3′ regions of genes, it does not 
explain how MOF is directed to promot-
ers. The new observation by Kind and 
coworkers of MOF binding to promoters 
does not depend on dosage compen-
sation or any of its components. This 
not only suggests an additional general 
function for MOF in the regulation of 
transcription, but also hints at an addi-
tional targeting mechanism to get MOF 
to promoters.
Clues to how MOF is directed to pro-
moters may be provided by the S. cer-
evisiae protein Eaf3, a homolog of MSL3 
that is associated with both the promot-
ers and transcribed regions of genes. 
Eaf3 is a member of both the NuA4 his-
tone acetyltransferase complex and an 
Rpd3 histone deacetylase complex (Car-
rozza et al., 2005; Eisen et al., 2001). Like 
MSL3, Eaf3 binds to methylated H3K36 
and directs the Rpd3 complex to the 
transcribed region of genes. However, 
Eaf3 is also localized to gene promoters 
as part of the NuA4 through the targeting 
action of sequence-specific DNA-bind-
Figure 1. Binding and Functions of the MOF Protein
The dosage compensation complex (DCC) of the fruit fly Drosophila melanogaster is recruited to the male 
X chromosome through DNA sequence-based elements (small bars within green box) recognized by the 
male-specific lethal proteins 1 (MSL1) and 2 (MSL2). The DCC spreads from these sites to target genes 
(red box, transcription start and direction indicated by arrow). Here, the DCC associates with the 3′ ends 
of transcribed regions via MSL3, which binds to trimethylated lysine 36 on histone H3 (H3K36; Me). MOF 
acetylates histone H4 lysine 16 (H4K16) at these 3′ regions (Ac). In females, MSL2 is not present, so 
the DCC cannot bind to the recruitment elements and does not spread to the 3′ region of genes. On all 
chromosomes in both female and male flies, MOF binds to the promoter regions and acetylates H4K16, 
presumably through interactions with an unknown protein or chromatin modification (gray oval).764 Cell 133, May 30, 2008 ©2008 Elsevier Inc.
ing transcription factors. It is possible 
that a similar strategy of targeting MOF 
to promoters with specific transcription 
factors or transcription machinery is 
present in the fly.
Several important questions with gen-
eral implications are brought to light by 
the Kind et al. study. What are the appar-
ently independent mechanisms of MOF 
targeting to the 5′ and 3′ ends of genes? 
Given that MOF acetylates H4K16 at both 
sites, what is the molecular function of 
H4K16 acetylation at these two regions? 
MOF is undoubtedly representative of 
many enzymes and chromatin-asso-
ciated proteins that perform different 
functions through regulated targeting. 
The answers to the questions raised by 
the new work should help to elucidate Although actin can polymerize into fila-
ments on its own, cells use an army of 
proteins to control the starting and stop-
ping of this reaction, as well as to orga-
nize the filaments into useful structures. 
Studying the function and regulation of 
these actin-modulating proteins has 
been the work of many labs for several 
decades. The control of actin dynam-
ics is not a mere academic curiosity, 
but plays a key role in physiological 
processes such as morphogenesis and 
immune system function as well as in 
diseases such as metastatic cancer.
Two important factors for controlling 
actin dynamics are the Arp2/3 complex, 
which nucleates new filaments and con-
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comitantly anchors them to the sides of 
existing filaments, and the capping pro-
tein, which binds to the rapidly growing 
barbed ends of filaments and terminates 
their growth (reviewed in Pollard and 
Borisy, 2003). Although these factors 
have been extensively studied in vitro, 
the relationship between their biochemi-
cal activities and their effects on motil-
ity is complex. This is particularly true 
of capping proteins that block filament 
growth yet enhance cell motility in vitro 
and in vivo (van der Gucht et al., 2005; 
Hug et al., 1995). One explanation for this 
paradoxical set of observations is the 
“actin funneling hypothesis,” which pos-
its that capping proteins enhance motil-
omer
d Department of Cell and Developmental Biolo
apel Hill, NC 27599, USA
ent growth, but paradoxically in
ling of actin monomers to the filam
ystem, Akin and Mullins (2008) 
 nucleation and branching, ratheLarschan, E., Alekseyenko, A.A., Gortchakov, A.A., 
Peng, S., Li, B., Yang, P., Workman, J.L., Park, P.J., 
and Kuroda, M.I. (2007). Mol. Cell 28, 121–133.
Lieb, J.D., Albrecht, M.R., Chuang, P.T., and Mey-
er, B.J. (1998). Cell 92, 265–277.
Liu, C.L., Kaplan, T., Kim, M., Buratowski, S., 
Schreiber, S.L., Friedman, N., and Rando, O.J. 
(2005). PLoS Biol. 3, e328.
Lyman, L.M., Copps, K., Rastelli, L., Kelley, R.L., 
and Kuroda, M.I. (1997). Genetics 147, 1743–
1753.
Mendjan, S., Taipale, M., Kind, J., Holz, H., Geb-
hardt, P., Schelder, M., Vermeulen, M., Buscaino, 
A., Duncan, K., Mueller, J., et al. (2006). Mol. Cell 
21, 811–823.
Shogren-Knaak, M., Ishii, H., Sun, J.M., Pazin, 
M.J., Davie, J.R., and Peterson, C.L. (2006). Sci-
ence 311, 844–847.
Straub, T., and Becker, P.B. (2007). Nat. Rev. Gen-
et. 8, 47–57.l 133, May 30, 2008 ©2008 Elsevier Inc. 765
ity by capping most actin filaments in 
the reaction and funneling the increased 
number of free actin monomers onto a 
small subset of filaments that grow with 
higher rates of elongation (Carlier and 
Pantaloni, 1997) (Figure 1A).
In their new study, Akin and Mullins 
(2008) re-examine this question and 
come to a strikingly different conclu-
sion about the role of capping protein 
in enhancing motility. They used an 
established in vitro motility system (Loi-
sel et al., 1999) comprising polystyrene 
beads coated with the Arp2/3-activator 
ActA. These beads were incubated in a 
precise mixture of purified protein com-
ponents including nonmuscle actin, the 
gy
crease actin-based cell motility. 
ent ends that remain uncapped. 
now demonstrate that filament 
r than elevating the rate of fila-
